Del-Sette Capital Management »

Regeneron Pharmaceuticals shares owned by Del-Sette Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Del-Sette Capital Management from 13F filings

Historical chart of Del-Sette Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Del-Sette Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Del-Sette Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 2.9k 771.87

More positions owned by Del-Sette Capital Management

Alps Etf Tr Intl Sec Dv Dog (IDOG)
Alps Etf Tr Em Sect Div Dg (EDOG)
First Tr Exchange-traded SHS (FDL)
Ishares Tr Msci Emg Mkt Etf (EEM)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Wisdomtree Tr Us Smallcap Divd (DES)
Dimensional Etf Trust Internatnal Val (DFIV)
Vanguard Admiral Fds SMLCP 600 GRTH (VIOG)
Cambria Etf Tr Global Value Etf (GVAL)
Pimco Etf Tr Active Bd Etf (BOND)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Dvlp (PIZ)
NVIDIA Corporation (NVDA)
Spdr Index Shs Fds Euro Stoxx 50 (FEZ)
Invesco SHS (IVZ)
Amazon (AMZN)

View all positions for Del-Sette Capital Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals